Nordea Investment Management AB Boosts Stake in Privia Health Group, Inc. (NASDAQ:PRVA)

Nordea Investment Management AB lifted its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 33.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 349,773 shares of the company’s stock after acquiring an additional 86,910 shares during the quarter. Nordea Investment Management AB owned 0.29% of Privia Health Group worth $6,953,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Victory Capital Management Inc. raised its position in shares of Privia Health Group by 402.9% in the 3rd quarter. Victory Capital Management Inc. now owns 179,049 shares of the company’s stock valued at $3,260,000 after purchasing an additional 143,446 shares in the last quarter. Franklin Resources Inc. boosted its stake in Privia Health Group by 2.2% during the 3rd quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock valued at $23,092,000 after acquiring an additional 28,480 shares during the last quarter. Barclays PLC grew its holdings in Privia Health Group by 240.3% during the 3rd quarter. Barclays PLC now owns 224,018 shares of the company’s stock worth $4,079,000 after acquiring an additional 158,188 shares in the last quarter. GAMMA Investing LLC increased its position in shares of Privia Health Group by 98.7% in the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock worth $31,000 after purchasing an additional 845 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in shares of Privia Health Group in the 3rd quarter valued at about $1,206,000. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Price Performance

PRVA stock opened at $20.93 on Friday. The firm has a market cap of $2.51 billion, a PE ratio of 209.32, a P/E/G ratio of 5.45 and a beta of 0.85. Privia Health Group, Inc. has a 12 month low of $15.92 and a 12 month high of $23.78. The firm has a 50 day simple moving average of $20.90 and a 200 day simple moving average of $19.40.

Analysts Set New Price Targets

PRVA has been the subject of several research analyst reports. KeyCorp began coverage on Privia Health Group in a report on Friday, October 11th. They issued an “overweight” rating and a $23.00 price objective for the company. Macquarie began coverage on shares of Privia Health Group in a research note on Monday, December 16th. They set an “outperform” rating and a $25.00 target price for the company. Barclays lifted their price target on shares of Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a report on Friday, November 8th. Truist Financial increased their price objective on shares of Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Finally, Stephens reiterated an “overweight” rating and set a $26.00 price target on shares of Privia Health Group in a research report on Thursday, January 2nd. Two equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $24.88.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.